HEADER TRANSFERASE 11-AUG-05 2AN5 TITLE STRUCTURE OF HUMAN PNMT COMPLEXED WITH S-ADENOSYL- TITLE 2 HOMOCYSTEINE AND AN INHIBITOR, TRANS-(1S,2S)-2-AMINO-1- TITLE 3 TETRALOL COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHENYLETHANOLAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PNMTASE, NORADRENALINE N-METHYLTRANSFERASE; COMPND 5 EC: 2.1.1.28; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET17PNMT-HIS KEYWDS METHYLTRANSFERASE, INHIBITOR STRUCTURE, S-ADENOSYL-L- KEYWDS 2 METHIONINE, ADRENALINE SYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR C.L.GEE,J.D.A.TYNDALL,G.L.GRUNEWALD,Q.WU,M.J.MCLEISH, AUTHOR 2 J.L.MARTIN REVDAT 2 24-FEB-09 2AN5 1 VERSN REVDAT 1 14-MAR-06 2AN5 0 JRNL AUTH C.L.GEE,J.D.A.TYNDALL,G.L.GRUNEWALD,Q.WU, JRNL AUTH 2 M.J.MCLEISH,J.L.MARTIN JRNL TITL MODE OF BINDING OF METHYL ACCEPTOR SUBSTRATES TO JRNL TITL 2 THE ADRENALINE-SYNTHESIZING ENZYME JRNL TITL 3 PHENYLETHANOLAMINE N-METHYLTRANSFERASE: JRNL TITL 4 IMPLICATIONS FOR CATALYSIS JRNL REF BIOCHEMISTRY V. 44 16875 2005 JRNL REFN ISSN 0006-2960 JRNL PMID 16363801 JRNL DOI 10.1021/BI051636B REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.36 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29889 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2990 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2608 REMARK 3 BIN R VALUE (WORKING SET) : 0.3480 REMARK 3 BIN FREE R VALUE : 0.3970 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 300 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4162 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 81 REMARK 3 SOLVENT ATOMS : 172 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.95300 REMARK 3 B22 (A**2) : -8.95300 REMARK 3 B33 (A**2) : 17.90700 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.43 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.00 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 32.04 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SAH_MOD2.PARAM REMARK 3 PARAMETER FILE 4 : 194.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AN5 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 16-AUG-05. REMARK 100 THE RCSB ID CODE IS RCSB034088. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC MIRRORS (HIRES2) REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29890 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 38.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.820 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.87 REMARK 200 R MERGE FOR SHELL (I) : 0.46200 REMARK 200 R SYM FOR SHELL (I) : 0.00000 REMARK 200 FOR SHELL : 4.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB STRUCTURE 1HNN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, LICL, CACODYLATE, PH 6.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.75500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.01000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.01000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 140.63250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.01000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.01000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.87750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.01000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.01000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 140.63250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.01000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.01000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 46.87750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 93.75500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ENZYME IS ACTIVE AS A MONOMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 ASP A 5 REMARK 465 ARG A 6 REMARK 465 SER A 7 REMARK 465 PRO A 8 REMARK 465 ASN A 9 REMARK 465 ALA A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ASP A 15 REMARK 465 SER A 16 REMARK 465 ALA A 17 REMARK 465 PRO A 18 REMARK 465 GLY A 19 REMARK 465 GLN A 20 REMARK 465 ALA A 21 REMARK 465 ALA A 22 REMARK 465 GLY A 281 REMARK 465 LEU A 282 REMARK 465 GLU A 283 REMARK 465 HIS A 284 REMARK 465 HIS A 285 REMARK 465 HIS A 286 REMARK 465 HIS A 287 REMARK 465 HIS A 288 REMARK 465 HIS A 289 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 ASP B 5 REMARK 465 ARG B 6 REMARK 465 SER B 7 REMARK 465 PRO B 8 REMARK 465 ASN B 9 REMARK 465 ALA B 10 REMARK 465 GLY B 11 REMARK 465 ALA B 12 REMARK 465 ALA B 13 REMARK 465 LEU B 282 REMARK 465 GLU B 283 REMARK 465 HIS B 284 REMARK 465 HIS B 285 REMARK 465 HIS B 286 REMARK 465 HIS B 287 REMARK 465 HIS B 288 REMARK 465 HIS B 289 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 27 0.70 -69.90 REMARK 500 ASP A 101 145.53 173.91 REMARK 500 GLU A 116 36.09 78.36 REMARK 500 PRO A 162 -3.74 -58.30 REMARK 500 CYS A 183 -70.09 -114.38 REMARK 500 ASP A 267 -174.60 -172.40 REMARK 500 ALA B 224 55.59 -142.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 1501 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH A 1301 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SAH B 2301 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TTL A 1401 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TTL B 2401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HNN RELATED DB: PDB REMARK 900 RELATED ID: 1N7I RELATED DB: PDB REMARK 900 RELATED ID: 1N7J RELATED DB: PDB REMARK 900 RELATED ID: 1YZ3 RELATED DB: PDB REMARK 900 RELATED ID: 2AN3 RELATED DB: PDB REMARK 900 RELATED ID: 2AN4 RELATED DB: PDB DBREF 2AN5 A 1 282 UNP P11086 PNMT_HUMAN 1 282 DBREF 2AN5 B 1 282 UNP P11086 PNMT_HUMAN 1 282 SEQADV 2AN5 GLU A 283 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 284 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 285 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 286 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 287 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 288 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS A 289 UNP P11086 EXPRESSION TAG SEQADV 2AN5 GLU B 283 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 284 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 285 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 286 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 287 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 288 UNP P11086 EXPRESSION TAG SEQADV 2AN5 HIS B 289 UNP P11086 EXPRESSION TAG SEQRES 1 A 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 A 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 A 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 A 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 A 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 A 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 A 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 A 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 A 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 A 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 A 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 A 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 A 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 A 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 A 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 A 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 A 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 A 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 A 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 A 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 A 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 A 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS SEQRES 1 B 289 MET SER GLY ALA ASP ARG SER PRO ASN ALA GLY ALA ALA SEQRES 2 B 289 PRO ASP SER ALA PRO GLY GLN ALA ALA VAL ALA SER ALA SEQRES 3 B 289 TYR GLN ARG PHE GLU PRO ARG ALA TYR LEU ARG ASN ASN SEQRES 4 B 289 TYR ALA PRO PRO ARG GLY ASP LEU CYS ASN PRO ASN GLY SEQRES 5 B 289 VAL GLY PRO TRP LYS LEU ARG CYS LEU ALA GLN THR PHE SEQRES 6 B 289 ALA THR GLY GLU VAL SER GLY ARG THR LEU ILE ASP ILE SEQRES 7 B 289 GLY SER GLY PRO THR VAL TYR GLN LEU LEU SER ALA CYS SEQRES 8 B 289 SER HIS PHE GLU ASP ILE THR MET THR ASP PHE LEU GLU SEQRES 9 B 289 VAL ASN ARG GLN GLU LEU GLY ARG TRP LEU GLN GLU GLU SEQRES 10 B 289 PRO GLY ALA PHE ASN TRP SER MET TYR SER GLN HIS ALA SEQRES 11 B 289 CYS LEU ILE GLU GLY LYS GLY GLU CYS TRP GLN ASP LYS SEQRES 12 B 289 GLU ARG GLN LEU ARG ALA ARG VAL LYS ARG VAL LEU PRO SEQRES 13 B 289 ILE ASP VAL HIS GLN PRO GLN PRO LEU GLY ALA GLY SER SEQRES 14 B 289 PRO ALA PRO LEU PRO ALA ASP ALA LEU VAL SER ALA PHE SEQRES 15 B 289 CYS LEU GLU ALA VAL SER PRO ASP LEU ALA SER PHE GLN SEQRES 16 B 289 ARG ALA LEU ASP HIS ILE THR THR LEU LEU ARG PRO GLY SEQRES 17 B 289 GLY HIS LEU LEU LEU ILE GLY ALA LEU GLU GLU SER TRP SEQRES 18 B 289 TYR LEU ALA GLY GLU ALA ARG LEU THR VAL VAL PRO VAL SEQRES 19 B 289 SER GLU GLU GLU VAL ARG GLU ALA LEU VAL ARG SER GLY SEQRES 20 B 289 TYR LYS VAL ARG ASP LEU ARG THR TYR ILE MET PRO ALA SEQRES 21 B 289 HIS LEU GLN THR GLY VAL ASP ASP VAL LYS GLY VAL PHE SEQRES 22 B 289 PHE ALA TRP ALA GLN LYS VAL GLY LEU GLU HIS HIS HIS SEQRES 23 B 289 HIS HIS HIS HET PO4 B1501 5 HET SAH A1301 26 HET SAH B2301 26 HET TTL A1401 12 HET TTL B2401 12 HETNAM PO4 PHOSPHATE ION HETNAM SAH S-ADENOSYL-L-HOMOCYSTEINE HETNAM TTL TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1- HETNAM 2 TTL OL HETSYN TTL TRANS-(1S,2S)-1-HYDROXY-2-AMINO-1,2,3,4 HETSYN 2 TTL TETRAHYDRONAPHTHALENE, TRANS-(1S,2S)-2-AMINO-1- HETSYN 3 TTL TETRALOL FORMUL 3 PO4 O4 P 3- FORMUL 4 SAH 2(C14 H20 N6 O5 S) FORMUL 6 TTL 2(C10 H13 N O) FORMUL 8 HOH *172(H2 O) HELIX 1 1 SER A 25 ARG A 29 5 5 HELIX 2 2 GLU A 31 TYR A 40 1 10 HELIX 3 3 GLY A 52 ALA A 66 1 15 HELIX 4 4 VAL A 84 LEU A 88 5 5 HELIX 5 5 SER A 89 HIS A 93 5 5 HELIX 6 6 LEU A 103 GLU A 116 1 14 HELIX 7 7 TRP A 123 GLY A 135 1 13 HELIX 8 8 CYS A 139 ARG A 150 1 12 HELIX 9 9 CYS A 183 VAL A 187 5 5 HELIX 10 10 ASP A 190 THR A 203 1 14 HELIX 11 11 SER A 235 SER A 246 1 12 HELIX 12 12 PRO A 259 GLN A 263 5 5 HELIX 13 13 SER B 16 TYR B 27 1 12 HELIX 14 14 GLN B 28 PHE B 30 5 3 HELIX 15 15 GLU B 31 ALA B 41 1 11 HELIX 16 16 GLY B 52 ALA B 66 1 15 HELIX 17 17 VAL B 84 LEU B 88 5 5 HELIX 18 18 ALA B 90 PHE B 94 5 5 HELIX 19 19 LEU B 103 GLN B 115 1 13 HELIX 20 20 TRP B 123 GLY B 135 1 13 HELIX 21 21 CYS B 139 ARG B 150 1 12 HELIX 22 22 CYS B 183 SER B 188 1 6 HELIX 23 23 ASP B 190 THR B 203 1 14 HELIX 24 24 SER B 235 SER B 246 1 12 HELIX 25 25 PRO B 259 GLN B 263 5 5 SHEET 1 A 7 VAL A 151 LEU A 155 0 SHEET 2 A 7 ASP A 96 THR A 100 1 N MET A 99 O ARG A 153 SHEET 3 A 7 THR A 74 ASP A 77 1 N ASP A 77 O THR A 98 SHEET 4 A 7 ALA A 175 ALA A 181 1 O VAL A 179 N ILE A 76 SHEET 5 A 7 LEU A 205 LEU A 217 1 O HIS A 210 N LEU A 178 SHEET 6 A 7 GLY A 271 LYS A 279 -1 O ALA A 277 N LEU A 211 SHEET 7 A 7 TYR A 248 ILE A 257 -1 N ASP A 252 O TRP A 276 SHEET 1 B 2 TRP A 221 ALA A 224 0 SHEET 2 B 2 ALA A 227 THR A 230 -1 O ALA A 227 N ALA A 224 SHEET 1 C 7 VAL B 151 PRO B 156 0 SHEET 2 C 7 ASP B 96 ASP B 101 1 N MET B 99 O ARG B 153 SHEET 3 C 7 THR B 74 ILE B 78 1 N ASP B 77 O THR B 98 SHEET 4 C 7 ALA B 175 ALA B 181 1 O VAL B 179 N ILE B 78 SHEET 5 C 7 LEU B 205 LEU B 217 1 O ILE B 214 N SER B 180 SHEET 6 C 7 GLY B 271 LYS B 279 -1 O GLY B 271 N LEU B 217 SHEET 7 C 7 TYR B 248 ILE B 257 -1 N ASP B 252 O TRP B 276 SHEET 1 D 2 TRP B 221 ALA B 224 0 SHEET 2 D 2 ALA B 227 THR B 230 -1 O LEU B 229 N TYR B 222 SSBOND 1 CYS A 48 CYS B 139 1555 1555 2.05 SSBOND 2 CYS A 139 CYS B 48 1555 1555 2.04 CISPEP 1 PRO A 42 PRO A 43 0 0.23 CISPEP 2 LEU A 173 PRO A 174 0 -0.22 CISPEP 3 PRO B 42 PRO B 43 0 0.33 CISPEP 4 LEU B 173 PRO B 174 0 -0.12 SITE 1 AC1 4 ASN B 122 GLU B 144 ARG B 148 HOH B1021 SITE 1 AC2 19 TYR A 27 TYR A 35 TYR A 40 GLY A 79 SITE 2 AC2 19 SER A 80 GLY A 81 THR A 83 TYR A 85 SITE 3 AC2 19 ASP A 101 PHE A 102 LEU A 103 ASN A 106 SITE 4 AC2 19 ASP A 158 VAL A 159 HIS A 160 ALA A 181 SITE 5 AC2 19 PHE A 182 CYS A 183 VAL A 187 SITE 1 AC3 21 TYR B 27 TYR B 35 TYR B 40 GLY B 79 SITE 2 AC3 21 SER B 80 GLY B 81 THR B 83 TYR B 85 SITE 3 AC3 21 ASP B 101 PHE B 102 LEU B 103 ASN B 106 SITE 4 AC3 21 ILE B 157 ASP B 158 VAL B 159 HIS B 160 SITE 5 AC3 21 ALA B 181 PHE B 182 CYS B 183 VAL B 187 SITE 6 AC3 21 HOH B1018 SITE 1 AC4 10 TYR A 35 ASN A 39 TYR A 40 ARG A 44 SITE 2 AC4 10 LYS A 57 PHE A 182 GLU A 219 MET A 258 SITE 3 AC4 10 ASP A 267 HOH A1049 SITE 1 AC5 9 TYR B 35 ASN B 39 ARG B 44 LYS B 57 SITE 2 AC5 9 PHE B 182 GLU B 219 MET B 258 ASP B 267 SITE 3 AC5 9 HOH B1018 CRYST1 94.020 94.020 187.510 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010636 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010636 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005333 0.00000 MASTER 351 0 5 25 18 0 18 6 0 0 0 46 END